Evidence map›Paper›PMID 33288767›Full record

ArticleNature communications2020

Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.

Deli Huang, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mary Tenuta, Mariia V Guryleva, Roberta P Fuller, Torben Schiffner, Justin R Abadejos, Lauren Couvrette and 10 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Adenoviral vectors infect B lymphocytes in vivo.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 5 countries.

Deli HuangDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-6989-639X
Jenny Tuyet TranDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Alex OlsonDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Thomas VollbrechtDepartment of Medicine, The University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-1151-8844
Mary TenutaDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-0708-3932
Mariia V GurylevaDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Roberta P FullerDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Torben SchiffnerDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Justin R AbadejosDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-8271-627X
Lauren CouvretteDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Tanya R BlaneDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Karen SayeDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Wenjuan LiDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Elise LandaisDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Alicia Gonzalez-MartinDepartment of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain.
William SchiefDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-1120-0150
Ben MurrellDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. benjamin.murrell@ki.se.ORCID http://orcid.org/0000-0002-0393-4445
Dennis R BurtonDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.ORCID http://orcid.org/0000-0001-6711-9864
David NemazeeDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. nemazee@scripps.edu.ORCID http://orcid.org/0000-0002-4769-6311
James E VossDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. jvoss@scripps.edu.ORCID http://orcid.org/0000-0002-4777-1596
Scripps Research Institute · USInstituto de Investigaciones Biomédicas Sols-Morreale · ESKarolinska Institutet · SELomonosov Moscow State University · RUUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20304-y.

Identifiers

PMID33288767
PMCPMC7720436
OpenAlexW3110798544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.